Atlas Trials

A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

Clinical trial NCT03494296 · RECRUITING

Trial details

NCT number
NCT03494296
Sponsor
First Affiliated Hospital of Harbin Medical University
Status
RECRUITING
Study type
OBSERVATIONAL
Lymphoma
Start date
2018-03-01
Primary completion
2020-12-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.